Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR-TKIs

The present study assessed whether estrogen receptor (ER)β1 is associated with the survival of patients with advanced lung adenocarcinoma, with or without mutations of the epidermal growth factor receptor (EGFR) following treatment with EGFR-tyrosine kinase inhibitors (TKIs). Pathologically confirme...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Cheng, He, Yifu, Luo, Huiqin, Zhang, Ming, Wu, Jing, He, Xiaofang, Fu, Yuying, Chen, Wenju, Zou, Jinkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540184/
https://www.ncbi.nlm.nih.gov/pubmed/31289556
http://dx.doi.org/10.3892/ol.2019.10348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540184/
https://www.ncbi.nlm.nih.gov/pubmed/31289556
http://dx.doi.org/10.3892/ol.2019.10348

Ejemplares similares